Search

everythinglearnresearchcommunity

for

Search:↓

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Heptaminol may cause hair lightening in hemodialysis patients.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Older female squirrel monkeys often experience a type of hair loss similar to chronic telogen effluvium in humans.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

More grafts and longer surgeries increase the risk of hair loss in the donor area after FUE hair transplants.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

A drug helped quickly reduce a movement disorder, experts debated the severity of Raynaud phenomenon, and rapid weight loss was linked to temporary hair loss with good recovery.

COVID-19 may cause a common type of hair loss called telogen effluvium.

The Modified Wash Test is reliable for diagnosing hair loss conditions and determining treatment priority.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.